Mast cells mediate malignant pleural effusion formation

Journal of Clinical Investigation

Volumn 125, Issue 6, 2015, Pages 2317-2334

  Giannou, Anastasios D ^a   Marazioti, Antonia ^a   Spella, Magda ^a   Kanellakis, Nikolaos I ^a   Apostolopoulou, Hara ^a   Psallidas, Ioannis ^a,b   Prijovich, Zeljko M ^a   Vreka, Malamati ^a   Zazara, Dimitra E ^a   Lilis, Ioannis ^a   Papaleonidopoulos, Vassilios ^a   Kairi, Chrysoula A ^a,c   Patmanidi, Alexandra L ^a   Giopanou, Ioanna ^a   Spiropoulou, Nikolitsa ^a   Harokopos, Vaggelis ^d   Aidinis, Vassilis ^e   Spyratos, Dionisios ^f   Teliousi, Stamatia ^g   Papadaki, Helen ^a   Taraviras, Stavros ^a   Snyder, Linda A ^h   Eickelberg, Oliver ⁱ   Kardamakis, Dimitrios ^a   Iwakura, Yoichiro ^j   Feyerabend, Thorsten B ^k   Rodewald, Hans Reimer ^k   Kalomenidis, Ioannis ^c   Blackwell, Timothy S ^l   Agalioti, Theodora ^a   Stathopoulos, Georgios T ^a,c,i,l   more..

^a UNIVERSITY OF PATRAS   (Greece)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

^e Biomedical Sciences Research Center   (Greece)

^f ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^g G PAPANICOLAOU HOSPITAL   (Greece)

^h Janssen R and D LLC   (United States)

ⁱ LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^j TOKYO UNIVERSITY OF SCIENCE   (Japan)

^k GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^l VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHLORDANE; IMATINIB; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; NOTCH RECEPTOR; OSTEOPONTIN; STAT3 PROTEIN; BENZAMIDE DERIVATIVE; IL1B PROTEIN, HUMAN; IL1B PROTEIN, MOUSE; PIPERAZINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRIMIDINE DERIVATIVE; STEM CELL FACTOR RECEPTOR; TPSAB1 PROTEIN, MOUSE; TRYPTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL PROLIFERATION; COLON ADENOCARCINOMA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LUNG ADENOCARCINOMA; MALIGNANT PLEURA EFFUSION; MAST CELL; MAST CELL DEGRANULATION; MICROARRAY ANALYSIS; MOUSE; MOUSE MODEL; NONHUMAN; PLEURA CAVITY; PRIORITY JOURNAL; TUMOR GROWTH; ADENOCARCINOMA; ANIMAL; ANTAGONISTS AND INHIBITORS; COLONIC NEOPLASMS; DIET THERAPY; GENETICS; LUNG TUMOR; MALE; METABOLISM; NONOBESE DIABETIC MOUSE; PATHOLOGY; PLEURAL EFFUSION, MALIGNANT; SCID MOUSE; TRANSGENIC MOUSE; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; BENZAMIDES; CELL LINE, TUMOR; COLONIC NEOPLASMS; HUMANS; IMATINIB MESYLATE; INTERLEUKIN-1BETA; LUNG NEOPLASMS; MALE; MAST CELLS; MICE; MICE, INBRED NOD; MICE, SCID; MICE, TRANSGENIC; PIPERAZINES; PLEURAL CAVITY; PLEURAL EFFUSION, MALIGNANT; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES; TRYPTASES;

EID: 84930400269     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI79840     Document Type: Article

References (59)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell. 2011;144(5): 646-674.
2. Swamy M, Jamora C, Havran W, Hayday A. Epithelial decision makers: In search of the 'epimmunome'. Nat Immunol. 2010;11(8): 656-665.
3. Coussens LM, Pollard JW. Leukocytes in mammary development and cancer. Cold Spring Harb Perspect Biol. 2011;3(3): A003285.
4. Floor SL, Dumont JE, Maenhaut C, Raspe E. Hallmarks of cancer: Of all cancer cells, all the time? Trends Mol Med. 2012;18(9): 509-515.
5. Balkwill FR, Mantovani A. Cancer-related inflammation: Common themes and therapeutic opportunities. Semin Cancer Biol. 2012;22(1): 33-40.
6. Soucek L, Lawlor ER, Soto D, Shchors K, Swigart LB, Evan GI. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat Med. 2007;13(10): 1211-1218.
7. Theoharides TC. Mast cells and pancreatic cancer. N Engl J Med. 2008;358(17): 1860-1861.
8. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: Recent advances. Annu Rev Immunol. 2005;23: 749-786.
9. Theoharides TC, Kempuraj D, Tagen M, Conti P, Kalogeromitros D. Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev. 2007;217: 65-78.
10. Chen R, et al. Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J Clin Invest. 2001;108(8): 1151-1158.
11. Blair RJ, et al. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest. 1997;99(11): 2691-2700.
12. Sinnamon MJ, Carter KJ, Sims LP, Lafleur B, Fingleton B, Matrisian LM. A protective role of mast cells in intestinal tumorigenesis. Carcinogenesis. 2008;29(4): 880-886.
13. Dalton DK, Noelle RJ. The roles of mast cells in anticancer immunity. Cancer Immunol Immunother. 2012;61(9): 1511-1520.
14. Pittoni P, Colombo MP. The dark side of mast cell-targeted therapy in prostate cancer. Cancer Res. 2012;72(4): 831-835.
15. Feyerabend TB, et al. Cre-mediated cell ablation contests mast cell contribution in models of antibody- And T cell-mediated autoimmunity. Immunity. 2011;35(5): 832-844.
16. Dudeck A, et al. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity. 2011;34(6): 973-984.
17. Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010; 65(suppl 2): Ii32-ii40.
18. Ryu JS, et al. Prognostic impact of minimal pleural effusion in non-small-cell lung cancer. J Clin Oncol. 2014;32(9): 960-967.
19. Burgers JA, Kunst PW, Koolen MG, Willems LN, Burgers JS, van den Heuvel M. Pleural drainage and pleurodesis: Implementation of guidelines in four hospitals. Eur Respir J. 2008;32(5): 1321-1327.
20. Davies HE, Lee YC. Management of malignant pleural effusions: Questions that need answers. Curr Opin Pulm Med. 2013;19(4): 374-379.
21. Postmus PE, et al. The IASLC Lung Cancer Staging Project: Proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J Thorac Oncol. 2007;2(8): 686-693.
22. Wu SG, et al. Survival of lung adenocarcinoma patients with malignant pleural effusion. Eur Respir J. 2013;41(6): 1409-1418.
23. Stathopoulos GT, Kalomenidis I. Malignant pleural effusion: Tumor-host interactions unleashed. Am J Respir Crit Care Med. 2012;186(6): 487-492.
24. Marazioti A, Blackwell TS, Stathopoulos GT. The lymphatic system in malignant pleural effusion. Drain or immune switch? Am J Respir Crit Care Med. 2014;189(6): 626-627.
25. Stathopoulos GT, et al. A central role for tumor-derived monocyte chemoattractant protein- 1 in malignant pleural effusion. J Natl Cancer Inst. 2008;100(20): 1464-1476.
26. Stathopoulos GT, et al. Host derived interleukin-5 promotes adenocarcinoma-induced malignantpleural effusion. Am J Respir Crit Care Med. 2010;182(10): 1273-1281.
27. Murdoch C, Muthana M, Coffelt SB, Lewis CE. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer. 2008;8(8): 618-631.
28. Ema H, et al. Adult mouse hematopoietic stem cells: Purification and single-cell assays. Nat Protoc. 2006;1(6): 2979-2987.
29. Brickshawana A, Shapiro VS, Kita H, Pease LR. Lineage(-)Sca1+c-Kit(-)CD25+ cells are IL-33-responsive type 2 innate cells in the mouse bone marrow. J Immunol. 2011;187(11): 5795-5804.
30. Tono T, et al. c-kit Gene was not transcribed in cultured mast cells of mast cell-deficient Wsh/ Wsh mice that have a normal number of erythrocytes and a normal c-kit coding region. Blood. 1992;80(6): 1448-1453.
31. Okayama Y, Kawakami T. Development, migration, and survival of mast cells. Immunol Res. 2006;34(2): 97-115.
32. Muzumdar MD, Tasic B, Miyamichi K, Li L, Luo L. A global double-fluorescent Cre reporter mouse. Genesis. 2007;45(9): 593-605.
33. Cao YA, et al. Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc Natl Acad Sci U S A. 2004;101(1): 221-226.
34. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 1997;407(3): 313-319.
35. Chen J, et al. Adoptive transfer of syngeneic bone marrow-derived cells in mice with obesity-induced diabetes: Selenoorganic antioxidant ebselen restores stem cell competence. Am J Pathol. 2009;174(2): 701-711.
36. Kitaura J, et al. IgE- And IgE+Ag-mediated mast cell migration in an autocrine/paracrine fashion. Blood. 2005;105(8): 3222-3229.
37. Tsui P, et al. Generation, characterization and biological activity of CCL2 (MCP-1/JE) and CCL12 (MCP-5) specific antibodies. Hum Antibodies. 2007;16(3-4): 117-125.
38. Marazioti A, et al. Beneficial impact of CCL2 and CCL12 neutralization on experimental malignant pleural effusion. PLoS One. 2013;8(8): E71207.
39. Wolters PJ, et al. Tissue-selective mast cell reconstitution and differential lung gene expression in mast cell-deficient Kit(W-sh)/Kit(W-sh) sash mice. Clin Exp Allergy. 2005;35(1): 82-88.
40. Yamazaki M, et al. C-kit gene is expressed by skin mast cells in embryos but not in puppies of Wsh/ Wsh mice: Age-dependent abolishment of c-kit gene expression. Blood. 1994;83(12): 3509-3516.
41. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Förster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 1999;8(4): 265-277.
42. Voehringer D, Liang HE, Locksley RM. Homeostasis and effector function of lymphopenia- induced "memory-like" T cells in constitutively T cell-depleted mice. J Immunol. 2008;180(7): 4742-4753.
43. Psallidas I, et al. Secreted phosphoprotein-1 directly provokes vascular leakage to fos- ter malignant pleural effusion. Oncogene. 2013;32(4): 528-535.
44. Horai R, et al. Production of mice deficient in genes for interleukin (IL)-1a, IL-1β, IL-1a/β, and IL-1 receptor antagonist shows that IL-1β is crucial in turpentine-induced fever development and glucocorticoid secretion. J Exp Med. 1998;187(9): 1463-1475.
45. Ling J, et al. KrasG12D-induced IKK2/β/NF-?B activation by IL-1a and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell. 2012;21(1): 105-120.
46. Greten FR, et al. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-Associated cancer. Cell. 2004;118(3): 285-296.
47. Stathopoulos GT, et al. Nuclear factor-?B affects tumor progression in a mouse model of malignant pleural effusion. Am J Respir Cell Mol Biol. 2006;34(2): 142-150.
48. Stathopoulos GT, et al. Tumor necrosis factor-A promotes malignant pleural effusion. Cancer Res. 2007;67(20): 9825-9834.
49. Chen CC, Grimbaldeston MA, Tsai M, Weissman IL, Galli SJ. Identification of mast cell progenitors in adult mice. Proc Natl Acad Sci U S A. 2005;102(32): 11408-11413.
50. Maaninka K, Lappalainen J, Kovanen PT. Human mast cells arise from a common circulating progenitor. J Allergy Clin Immunol. 2013;132(2): 463-469.
51. Zhang Y, Ramos BF, Jakschik BA. Augmentation of reverse arthus reaction by mast cells in mice. J Clin Invest. 1991;88(3): 841-846.
52. Tilley SL, Wagoner VA, Salvatore CA, Jacobson MA, Koller BH. Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells. J Clin Invest. 2000;105(3): 361-367.
53. Prieto-García A, et al. Mast cell restricted mouse and human tryptasėheparin complexes hinder thrombin-induced coagulation of plasma and the generation of fibrin by proteolytically destroying fibrinogen. J Biol Chem. 2012;287(11): 7834-7844.
54. DiDonato JA, Mercurio F, Karin M. NF-?B and the link between inflammation and cancer. Immunol Rev. 2012;246(1): 379-400.
55. Dong G, Chen Z, Kato T, Van Waes C. The host environment promotes the constitutive activation of nuclear factor-?B and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma. Cancer Res. 1999;59(14): 3495-3504.
56. Nakamura Y, Franchi L, Kambe N, Meng G, Strober W, Nez G. Critical role for mast cells in interleukin-1β-driven skin inflammation associated with an activating mutation in the nlrp3 protein. Immunity. 2012;37(1): 85-95.
57. Yeh HH, Lai WW, Chen HH, Liu HS, Su WC. Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion. Oncogene. 2006;25(31): 4300-4309.
58. Fujiwara M, Ishida Y, Nimura N, Toyama A, Kinoshita T. Postcolumn fluorometric detection system for liquid chromatographic analysis of amino and imino acids using o-phthalaldehyde/ N-Acetyl-L-cysteine reagent. Anal Biochem. 1987;166(1): 72-78.
59. Faul F, Erdfelder E, Lang AG, Buchner A. G∗Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods. 2007;39(2): 175-191.